Blood loss at the time of dilation and evacuation at 16 to 22 weeks of gestation in women using low molecular weight heparin: A case series

Mary Tschann; Alison Edelman; Jeffrey Jensen; Paula Bednarek; Bliss Kaneshiro

doi:10.1016/j.contraception.2017.09.002

Blood loss at the time of dilation and evacuation at 16 to 22 weeks of gestation in women using low molecular weight heparin: A case series

Mary Tschann, Alison Edelman, Jeffrey Jensen, Paula Bednarek, Bliss Kaneshiro

Obstetrics & Gynecology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Objective: Describe blood loss with surgical abortion ≥16. weeks of gestation in anticoagulated patients. Study design: Clinicians involved in a professional listserv (2011-2013) reported cases of abortion ≥16. weeks of gestation in anticoagulated women. Results: All 7 patients were using or had recently discontinued low molecular weight heparin (LMWH). One patient was reported to have greater than anticipated blood loss for gestational age. No patients required transfusion and no complications were reported. Conclusions: Our limited case series suggests D&E may not always be contraindicated in women with recent or current LMWH use.

Original language	English (US)
Journal	Contraception
DOIs	https://doi.org/10.1016/j.contraception.2017.09.002
State	Accepted/In press - 2017

Keywords

Abortion
Anticoagulant
Blood loss
Dilation
Evacuation

ASJC Scopus subject areas

Reproductive Medicine
Obstetrics and Gynecology

Access to Document

10.1016/j.contraception.2017.09.002

Fingerprint Dive into the research topics of 'Blood loss at the time of dilation and evacuation at 16 to 22 weeks of gestation in women using low molecular weight heparin: A case series'. Together they form a unique fingerprint.

Cite this

@article{d5dd2ee8c3784e87bc68012b917249c8,

title = "Blood loss at the time of dilation and evacuation at 16 to 22 weeks of gestation in women using low molecular weight heparin: A case series",

abstract = "Objective: Describe blood loss with surgical abortion ≥16. weeks of gestation in anticoagulated patients. Study design: Clinicians involved in a professional listserv (2011-2013) reported cases of abortion ≥16. weeks of gestation in anticoagulated women. Results: All 7 patients were using or had recently discontinued low molecular weight heparin (LMWH). One patient was reported to have greater than anticipated blood loss for gestational age. No patients required transfusion and no complications were reported. Conclusions: Our limited case series suggests D&E may not always be contraindicated in women with recent or current LMWH use.",

keywords = "Abortion, Anticoagulant, Blood loss, Dilation, Evacuation",

author = "Mary Tschann and Alison Edelman and Jeffrey Jensen and Paula Bednarek and Bliss Kaneshiro",

year = "2017",

doi = "10.1016/j.contraception.2017.09.002",

language = "English (US)",

journal = "Contraception",

issn = "0010-7824",

publisher = "Elsevier USA",

}

TY - JOUR

T1 - Blood loss at the time of dilation and evacuation at 16 to 22 weeks of gestation in women using low molecular weight heparin

T2 - A case series

AU - Tschann, Mary

AU - Edelman, Alison

AU - Jensen, Jeffrey

AU - Bednarek, Paula

AU - Kaneshiro, Bliss

PY - 2017

Y1 - 2017

N2 - Objective: Describe blood loss with surgical abortion ≥16. weeks of gestation in anticoagulated patients. Study design: Clinicians involved in a professional listserv (2011-2013) reported cases of abortion ≥16. weeks of gestation in anticoagulated women. Results: All 7 patients were using or had recently discontinued low molecular weight heparin (LMWH). One patient was reported to have greater than anticipated blood loss for gestational age. No patients required transfusion and no complications were reported. Conclusions: Our limited case series suggests D&E may not always be contraindicated in women with recent or current LMWH use.

AB - Objective: Describe blood loss with surgical abortion ≥16. weeks of gestation in anticoagulated patients. Study design: Clinicians involved in a professional listserv (2011-2013) reported cases of abortion ≥16. weeks of gestation in anticoagulated women. Results: All 7 patients were using or had recently discontinued low molecular weight heparin (LMWH). One patient was reported to have greater than anticipated blood loss for gestational age. No patients required transfusion and no complications were reported. Conclusions: Our limited case series suggests D&E may not always be contraindicated in women with recent or current LMWH use.

KW - Abortion

KW - Anticoagulant

KW - Blood loss

KW - Dilation

KW - Evacuation

UR - http://www.scopus.com/inward/record.url?scp=85030688410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030688410&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2017.09.002

DO - 10.1016/j.contraception.2017.09.002

M3 - Article

C2 - 28916484

AN - SCOPUS:85030688410

JO - Contraception

JF - Contraception

SN - 0010-7824

ER -

Blood loss at the time of dilation and evacuation at 16 to 22 weeks of gestation in women using low molecular weight heparin: A case series

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this